Dr. Sahar K. Rida, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 380 E Northwest Hwy, Suite 310, Des Plaines, IL 60016 Phone: 847-954-0112 Fax: 847-954-0313 |
Waheeda M Hirani, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd Ste 301, Des Plaines, IL 60016 Phone: 847-635-7300 Fax: 847-635-7556 |
Dr. Katherine Gehlmann Conner, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd Ste 301, Des Plaines, IL 60016 Phone: 847-635-7300 Fax: 847-635-7556 |
Dr. Suellyn S Rossman, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2434 E Dempster St Ste 206, Des Plaines, IL 60016 Phone: 847-297-2474 Fax: 847-297-2476 |
Sol Drapkin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd Ste 301, Des Plaines, IL 60016 Phone: 847-635-7300 Fax: 847-635-7556 |
News Archive
The bacteria residing in your digestive tract, or your gut microbiota, may play an important role in your ability to respond to chemotherapy drugs in the clinic, according to a new study by scientists at the University of Massachusetts Medical School.
In June 2019, WHO announced the revision of two pain management guidelines.
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.
ViaSat Inc., an innovator in broadband and communication technologies and services, is proud to announce it was recognized as one of the 2015 San Diego Business Journal 'Healthiest Companies' in the mega company category. This announcement comes as the Company holds its annual Wellness Week, with opportunities designed to educate and engage employees on healthy lifestyle choices.
Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson's disease (PD), but trials have been disappointing.
› Verified 8 days ago